What Streck does

Streck is a privately held biotechnology company founded in 1971 and headquartered in La Vista, Nebraska, with between 251 and 500 employees. The company develops and manufactures clinical laboratory quality control products and sample stabilization solutions built on a proprietary cell stabilization technology that preserves human blood cells at room temperature with extended closed-vial stability of up to 190 days for hematology controls and 90+ days for flow cytometry controls.

The product portfolio is organized across four disciplines: Hematology QC (Para 12 Extend, Para 12 Plus, Retic-Chex Linearity for BC, STaK-Chex Plus Retics), Flow Cytometry QC (the CD-Chex family including the May 2025-launched CD-Chex Daily with 51 assayed markers, CD-Chex Plus, CD-Chex CD34, CD-Chex CD103 Plus, CD-Chex CD117 Plus, CD-Chex TdT Plus, CD-Chex Select), Molecular Diagnostics QC (the MDx-Chex line validated across BIOFIRE FilmArray, Luminex VERIGENE, and LIAISON PLEX platforms for blood culture, respiratory, STI, and vaginitis panels, plus ARM-D antibiotic resistance kits and Blood Culture Verification Kits), and Specialized Testing (A1c-Cellular). A separate Sample Stabilization business supplies blood collection tubes (Cell-Free DNA BCT, Cyto-Chex BCT, Nucleic Acid BCT, Nucleic Acid Plus BCT) and reagents for liquid biopsy, immunophenotyping, and CNS applications. Supporting services include the free STATS interlaboratory quality comparison program and a Pipette Verification Service.

Streck's revenue model is consumables-driven: one-time unit sales of QC products and blood collection tubes to clinical laboratories, supplemented by recurring engagement through STATS (which is free but locks customers into peer-group benchmarking using Streck controls) and a small professional services line for pipette calibration. Distribution combines direct online ordering and quote-based sales for US/EU customers, an international distributor network for global reach, and strategic embedded partnerships with major diagnostic instrument manufacturers — BD Biosciences, Beckman Coulter, Abbott, Sysmex, Luminex, and bioMerieux — that incorporate Streck QC into their customer workflows. The company holds multiple FDA Class II clearances and IVDR EU Declarations of Conformity, positioning it as the standard third-party QC layer across the major clinical hematology and flow cytometry platforms. Leadership comprises founder Wayne Ryan and Chief Operating Officer John Noble; ownership is private with no disclosed venture capital, private equity, or parent company affiliation.

Name

Streck

Legal name

Streck

Website

https://streck.com

Company type

Private

Founded year

1971

Operating status

Operating

Headcount range

251–500 employees

Short description

Streck, founded in 1971 and headquartered in La Vista, Nebraska, manufactures proprietary stabilized blood quality controls and sample stabilization products for clinical laboratories across hematology, flow cytometry, molecular diagnostics, and specialized testing, selling globally through direct sales, distributors, and instrument-manufacturer partnerships.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Quality Controls and Sample Stabilization Reagents

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Hematology & Coagulation Diagnostics (HLAHAAAB)

akta.pro secondary industries

Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Blood Bank, Transfusion Medicine & Immunohematology (HLAHAAAH)

Keywords

• Clinical diagnostic reagents
• Hematology quality controls
• Flow cytometry controls
• Molecular diagnostic QC
• Blood collection tubes

Headquarters

HQ city

La Vista

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales, Infrastructure

Revenue model

1. Quality Control Products: Streck generates revenue through the sale of quality control products for hematology, flow cytometry, molecular diagnostics, and specialized testing. Products include whole blood controls, flow cytometry controls, and molecular diagnostic controls sold directly to clinical laboratories and through partnerships with instrument manufacturers.
2. Sample Stabilization Products: Revenue from blood collection tubes and stabilization reagents including Cell-Free DNA BCT, Cyto-Chex BCT, Nucleic Acid BCT, and related products that preserve sample integrity from collection to analysis.
3. STATS Interlaboratory Quality Control Program: Free interlaboratory quality control program that enables laboratories to compare results against peer groups using the same controls and analyzers. While the program itself is free, it drives customer loyalty and product differentiation.
4. Pipette Verification Service: Specialized service offering for pipette calibration and verification, supporting laboratory quality assurance requirements.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Core offering

Streck manufactures and sells stabilized whole-blood quality control products for clinical laboratories across four disciplines—Hematology, Flow Cytometry, Molecular Diagnostics, and Specialized Testing—along with blood collection tubes that preserve cell-free DNA, RNA, proteins, and leukocyte antigens at room temperature from collection through analysis. The portfolio includes assayed controls (e.g., Para 12 Extend, CD-Chex family, MDx-Chex family), BCT stabilization tubes (Cell-Free DNA BCT, Cyto-Chex BCT, Nucleic Acid BCT), and supporting services such as STATS peer-comparison program and Pipette Verification.

Product overview

Streck is a clinical laboratory products company founded in 1971 specializing in quality controls and sample stabilization solutions for clinical diagnostics. The company offers four product disciplines: Hematology Quality Controls (Para 12 Extend, Para 12 Plus, Retic-Chex Linearity for BC, STaK-Chex Plus Retics), Flow Cytometry Quality Controls (CD-Chex family including CD-Chex Daily with 51 markers, CD-Chex Plus, CD-Chex CD34, CD-Chex CD103 Plus, CD-Chex CD117 Plus, CD-Chex TdT Plus, CD-Chex Select), Molecular Diagnostics Quality Controls (MDx-Chex for BIOFIRE BCID2, VERIGENE BC-GP/BC-GN, LIAISON PLEX BCN/BCP/BCY, MDx-Chex for CT/NG/TV, MVP, RLP, RP, plus Blood Culture Verification Kits and ARM-D Kit for ampC resistance gene detection), and Specialized Testing Controls (A1c-Cellular). Sample stabilization includes Cell-Free DNA BCT, Cyto-Chex BCT, Nucleic Acid BCT, Nucleic Acid Plus BCT, Streck Cell Preservative, and Streck Urine Preserve. Supporting services include STATS interlaboratory comparison program and Pipet Verification Service. Products are designed to replicate patient samples with extended stability, room temperature storage options, and compatibility with major diagnostic instrument platforms including Beckman Coulter, BD Biosciences, Abbott, Luminex, and bioMerieux systems.

Differentiator

Problem solved

Functional benefit

Brands

• STATS: Interlaboratory Quality Control program enabling peer group data comparison
• Para 12
• CD-Chex
• MDx-Chex
• Cell-Free DNA BCT
• Cyto-Chex BCT
• ARM-D
• SICKLEDEX

Products and services

• Para 12 Extend Three-part differential hematology control with assay values at low, normal, and high levels for CBC verification. Compatible with Beckman Coulter, ERMA, Horiba Medical, HTI Diagnostics, Mindray, Nihon Kohden, and Siemens three-part hematology analyzers. Offers 30-day open-vial and 190-day closed-vial stability at room temperature.
• Para 12 Plus Five-part differential hematology control with complete assay values and barcoded labels for automated parameter onboarding, specifically formulated for the Abbott CELL-DYN Ruby analyzer. Offers 7-day open-vial and 75-day closed-vial stability.
• Retic-Chex Linearity for BC Assayed linearity control kit for verifying patient reportable ranges and measuring linear performance of automated and semi-automated hematology analyzers reporting reticulocyte parameters, with values specific to Beckman Coulter platforms.
• STaK-Chex Plus Retics Comprehensive whole blood five-part differential hematology control monitoring all CBC parameters including reticulocytes and NRBCs with barcoded labels for automated onboarding, designed for Beckman Coulter UniCel DxH 600/800/900/690T analyzers.
• CD-Chex CD34 FDA-cleared positive procedural control for enumerating CD34+ cells by flow cytometry, containing human leukocytes, erythrocytes, and CD34+ cells resembling hematopoietic progenitor cells. Compatible with ISHAGE protocol and BD Biosciences ProCOUNT/Stem Cell Enumeration kits.
• CD-Chex Plus FDA-cleared positive procedural control for T-lymphocyte, B-lymphocyte, and NK cell enumeration, assayed for 30 parameters with a CD34+ population and two clinically relevant CD4+ levels. Compatible with BD Biosciences, Beckman Coulter, and Accellix flow cytometry systems. Offers 30-day open-vial and 90-day closed-vial stability.
• CD-Chex Select Positive procedural flow cytometry control assayed for 11 CD markers used in immunophenotyping, including rare antigens and intracellular markers, compatible with BD Biosciences and Beckman Coulter systems and automated sample preparation instruments.
• CD-Chex CD117 Plus Ready-to-use control for evaluating CD117, CD25, and CD71 expression by flow cytometry, designed to resemble peripheral blood leukocytes found in hematolymphoid neoplastic samples. Compatible with BD Biosciences and Beckman Coulter systems.
• CD-Chex TdT Plus Ready-to-use flow cytometry control for evaluating CD2, CD4, CD5, CD7, CD8, CD34, cytoplasmic CD3, and nuclear TdT expression, containing an abnormally high CD34+ population to resemble acute leukemia patient samples. Compatible with BD Biosciences and Beckman Coulter systems.
• CD-Chex CD103 Plus Ready-to-use control for evaluating CD103, CD30, CD38, CD56, CD138, and cytoplasmic Lambda expression by flow cytometry. Contains two distinct abnormal leukocyte populations (CD45+ and CD45-) with CD30 and CD103 designated as rare flow antigens by CAP. Compatible with BD Biosciences and Beckman Coulter systems.
• CD-Chex Daily Stabilized whole blood flow cytometry control delivering 51 assayed RUO markers in a single vial (44 surface, 4 intracellular markers, and 3 leukocyte scatter populations), consolidating daily QC into one run and including markers not previously available in any commercial flow cytometry control (CD27, CD28, TRBC1, CD79b, CD81, CD45RA, CD45RO, CD36, CD24, IgM).
• MDx-Chex for BCID2 FDA Class II cleared patient-like full process molecular control for the BIOFIRE BCID2 Panel covering all 43 bacteria, yeasts, and antimicrobial resistance gene targets, used directly on BIOFIRE FilmArray Torch and 2.0 platforms with room temperature stability.
• MDx-Chex for BC-GP FDA Class II cleared full-process control for the Luminex VERIGENE BC-GP Panel validating automated nucleic acid extraction, DNA purification, microarray hybridization, and silver staining for gram-positive blood culture identification.
• MDx-Chex for BC-GN FDA Class II cleared full-process control for the Luminex VERIGENE BC-GN Panel validating the gram-negative blood culture identification workflow with room temperature stability and single-use vial format reducing preanalytical variables.
• MDx-Chex for BCN FDA Class II cleared full-process molecular quality control for the LIAISON PLEX Gram-Negative Blood Culture Assay. Contains intact inactivated microorganisms in stabilized blood-like matrix with room temperature stability and single-use vials reducing cross-contamination risk.
• MDx-Chex for BCP FDA Class II cleared full-process molecular quality control for the LIAISON PLEX Gram-Positive Blood Culture Assay validating the entire testing process from extraction to detection with pooled gram-positive targets in single vial.
• MDx-Chex for BCY FDA Class II cleared full-process molecular quality control for the LIAISON PLEX Yeast Blood Culture Assay validating the entire testing process with yeast targets in stabilized blood-like matrix with room temperature storage and single-use format.
• MDx-Chex for CT/NG/TV Full-process molecular quality control for validation of molecular assays detecting Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis. Platform agnostic with all three pathogens pooled in a single vial and patient-like matrix containing red blood cells and epithelial cells. For Research Use Only.
• MDx-Chex for MVP Full-process molecular quality control for validation of molecular assays identifying vaginitis-causing organisms including Bacterial vaginosis, Candida group, Candida-glab-krus, and Trichomonas vaginalis. Platform agnostic verified on multiple molecular platforms with room temperature stability. For Research Use Only.
• MDx-Chex for RLP Full-process molecular quality control covering Influenza A, Influenza B, Human Rhinovirus, RSV, SARS-CoV-2, and S. pyogenes (Group A Strep). Platform agnostic verified on multiple molecular platforms. Supports research, development, optimization, verification, and analytical performance assessment. For Research Use Only.
• MDx-Chex for RP Full-process molecular quality control for research, development, optimization, verification, and analytical performance assessment of laboratory high-plex assays targeting respiratory infections. Patient-like matrix of inactivated microorganisms and human cells. Compatible with bioMerieux respiratory panels. For Research Use Only.
• Blood Culture GP Verification Kit (RUO) Verification kit for validating molecular testing processes detecting gram-positive bacterial nucleic acids, usable for one-time validation and operator proficiency training in single-use vial format with room temperature storage.
• Blood Culture Yeast Verification Kit (RUO) Verification kit for validating molecular testing processes detecting yeast nucleic acids, containing 10 single-use positive tubes and 10 single-use negative tubes, usable for operator proficiency training. For Research Use Only.
• Blood Culture GN Verification Kit (RUO) Verification kit for validating molecular testing processes detecting gram-negative bacterial nucleic acids, supplied as two separate vials with different pathogen groups serving as negative controls for each other. Room temperature storage. For Research Use Only.
• ARM-D Kit, ampC Multiplex real-time PCR kit for rapid detection of AmpC beta-lactamase resistance genes in gram-negative bacteria, covering over 200 allelic variants across CMY02, DHA, ACC, EBC, FOX and MOX gene families. Includes positive controls and internal control (16SrRNA gene). Compatible with most 4-channel real-time PCR thermal cyclers including Applied Biosystems, Bio-Rad, QuantStudio, and QIAGEN platforms. CE IVD version available.
• A1c-Cellular Whole blood HbA1c control testing the entire procedure including the red blood cell lysis step, the only HbA1c control that includes this step. Ready-to-use without reconstitution for immunoassay and ionic exchange HPLC methodologies at two clinically significant levels. 30-day open-vial and 190-day closed-vial stability.
• Cell-Free DNA BCT Blood collection tube for protecting cell-free DNA from degradation and cellular uptake during sample collection, transport, and storage. Stabilizes cfDNA for liquid biopsy and non-invasive prenatal testing applications.
• Cyto-Chex BCT Blood collection tube for whole blood flow cytometry stabilization. Preserves cell surface markers and morphological characteristics during sample transport, enabling analysis of immunophenotyping samples collected at remote sites.
• Nucleic Acid BCT Blood collection tube for nucleic acid stabilization preserving cfDNA, cfRNA, and extracellular vesicles, enabling sample collection and transport for molecular diagnostics testing without immediate processing.
• Nucleic Acid Plus BCT Multi-analyte stabilization tube for preserving nucleic acids including cfDNA, cfRNA, and proteins in a single tube. Enables comprehensive molecular analysis from a single blood draw.
• Streck Cell Preservative Cell preservation solution for CNS liquid biopsy applications, enabling collection and stabilization of cerebrospinal fluid samples for molecular analysis.
• Streck Urine Preserve Nucleic acid preservation tube for urine samples, enabling collection, transport, and storage of urine specimens for molecular testing without degradation of nucleic acids.
• STATS ILQC Program Free interlaboratory quality control program enabling laboratories to compare QC performance against peer groups using the same controls and analyzers. Provides benchmarking data for quality improvement and regulatory compliance support.
• Pipet Verification Service Specialized service for verification and validation of pipette performance, ensuring accurate liquid handling in laboratory workflows and supporting compliance with quality management system requirements.

Quantifiable outcome

• Extended shelf life of up to 190 days reduces lot changes and correlation downtime
• +3 more outcomes

Named customers3 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration14 records

Feature5 records

Partnerships

Four partnerships are on record, tiered strategic and core.

• Metro Community College (MCC)strategicStrategic or Co-development Partner · 10 March 2026Streck partnered with Metro Community College in Nebraska to develop a biotechnology training program featuring flexible pathways from micro-credentials to an associate degree, backed by $770,663 NSF grant. The $3 million lab facility at Elkhorn Valley Campus is modeled after real industry facilities. Partnership addresses workforce shortage in Nebraska's biotech sector.
• EvonikstrategicStrategic or Co-development Partner · 10 March 2026Evonik is one of the biotech companies partnering with Metro Community College alongside Streck to support workforce development in Nebraska's biotechnology and manufacturing sector.
• Sysmex AmericacoreTechnology or IntegrationSysmex partners with Streck for quality control products for their hematology instruments. Sysmex CEO Dan Zortman has publicly endorsed the partnership: 'Our partnership with Streck reflects what is possible when two organizations align around quality, science, and service always with the customer at the center. Their expertise and responsiveness have supported our teams through complex development and validation efforts.'
• Instrument Manufacturers (BD Biosciences, Beckman Coulter, Abbott, Luminex, bioMerieux)coreTechnology or IntegrationLeading hematology analyzer and flow cytometer manufacturers partner with Streck to provide comprehensive third-party QC for their customers. Streck has validated compatibility with BD Biosciences, Beckman Coulter, Abbott, Luminex VERIGENE, bioMerieux BIOFIRE and LIAISON PLEX systems.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Bio-Rad Laboratories: Bio-Rad is a diversified life science and clinical diagnostics company that offers third-party QC controls for hematology, immunology, and molecular diagnostics — directly competing with Streck's core QC portfolio while also serving broader research and clinical lab markets.
• BD Biosciences: BD Biosciences is a major flow cytometry instrument manufacturer and a Streck partner, but also sells its own application reagents and could vertically integrate into QC controls, making it both a partner and a structural competitive threat.
• Beckman Coulter: Beckman Coulter is a leading hematology analyzer manufacturer and Streck partner. While it purchases Streck controls for its own platforms, Beckman Coulter is part of Danaher and could develop competing QC solutions through its broader diagnostics portfolio.
• Sysmex: Sysmex is a global hematology leader whose CEO publicly endorsed the Streck partnership. It represents both a key partnership customer and a competitive risk if Sysmex chose to develop proprietary controls for its installed base.
• Abbott Diagnostics: Abbott Diagnostics is a major hematology platform provider (CELL-DYN) and molecular diagnostics player. It validates Streck controls for its platforms but is a large diversified diagnostics competitor with the resources to enter QC directly.
• Roche Diagnostics: Roche Diagnostics is the largest global IVD player, offering broad QC, hematology, and molecular diagnostics products. Its scale and global reach create competitive pressure on niche QC specialists like Streck in enterprise lab accounts.
• Siemens Healthineers: Siemens Healthineers is a major hematology analyzer manufacturer and broader IVD player. Its scale across imaging, diagnostics, and laboratory solutions makes it both a Streck-compatible platform partner and a broad competitive threat.
• Thermo Fisher Scientific: Thermo Fisher is a global life sciences and diagnostics leader offering laboratory controls, reagents, and instruments. Its scale, R&D budget, and acquisition history make it a long-term competitive risk in the clinical QC space Streck occupies.
• Hologic: Hologic is a diagnostics and women's health company whose molecular diagnostic instruments represent an adjacent competitive threat. As Streck expands MDx-Chex into vaginitis and STI panels, Hologic's Panther systems become a relevant comparison for QC validation customers.

Emerging players

• DiaSorin: DiaSorin is an IVD company focused on specialty diagnostics and molecular testing. Its LIAISON platform partnership with Streck (MDx-Chex for BCN/BCP/BCY) makes it a peer-and-partner comparable for blood culture molecular QC adjacencies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/streckinc
• YouTubeyoutube.com/channel/UCb3LQ9sRg3Oqj8P4xq3lZ6w
• LinkedInlinkedin.com/company/streck
• Facebookfacebook.com/streck-275059322679158

Compliance14 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Streck